Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada
- PMID: 10530581
- DOI: 10.1097/00006454-199910000-00006
Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada
Abstract
Objective: We wished to compare outcomes of respiratory syncytial virus (RSV) infection in children with bronchopulmonary dysplasia (BPD) with those with other pulmonary disorders: cystic fibrosis, recurrent aspiration pneumonitis, pulmonary malformation, neurogenic disorders interfering with pulmonary toilet, and tracheoesophageal fistula.
Methods: Children with RSV infection hospitalized at seven Canadian pediatric tertiary care hospitals in 1993 through 1994 and 9 hospitals in 1994 through 1995 were enrolled and prospectively followed. This study is a secondary analysis of data from this prospective cohort.
Results: Of the 1516 patients enrolled the outcomes of 159 with preexisting lung disorders before RSV lower respiratory tract infection constitute this report. There were no significant differences among the 7 groups (BPD, cystic fibrosis, recurrent aspiration pneumonitis, pulmonary malformation, neurogenic disorders interfering with pulmonary toilet, tracheoesophageal fistula, other) for the morbidity measures: duration of hospitalization, intensive care unit (ICU) admission, duration of ICU stay, mechanical ventilation and duration of mechanical ventilation. Patients using home oxygen were more likely to be admitted to the ICU than those who had never or previously used home oxygen (current 57.1%, past 23.8%, never 33.3%, P = 0.03).
Conclusions: Children with other underlying diseases have morbidity similar to those with BPD. Prophylactic interventions against RSV should also be studied in these groups.
Similar articles
-
Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection.J Pediatr. 1996 Sep;129(3):390-5. doi: 10.1016/s0022-3476(96)70071-9. J Pediatr. 1996. PMID: 8804328
-
Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection.J Pediatr. 1995 Feb;126(2):212-9. doi: 10.1016/s0022-3476(95)70547-3. J Pediatr. 1995. PMID: 7844667
-
Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.Pediatrics. 1997 Mar;99(3):E7. doi: 10.1542/peds.99.3.e7. Pediatrics. 1997. PMID: 9099772 Clinical Trial.
-
Testing models predicting severity of respiratory syncytial virus infection on the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada.Arch Pediatr Adolesc Med. 1995 Nov;149(11):1217-20. doi: 10.1001/archpedi.1995.02170240035005. Arch Pediatr Adolesc Med. 1995. PMID: 7581752 Review.
-
Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a Pediatric Investigators Collaborative Network on Infections in Canada Study.Pediatrics. 1997 Dec;100(6):943-6. doi: 10.1542/peds.100.6.943. Pediatrics. 1997. PMID: 9374561 Review.
Cited by
-
Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review.Syst Rev. 2020 Nov 25;9(1):269. doi: 10.1186/s13643-020-01527-y. Syst Rev. 2020. PMID: 33239107 Free PMC article.
-
Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes.Influenza Other Respir Viruses. 2020 Nov;14(6):658-670. doi: 10.1111/irv.12729. Epub 2020 Feb 16. Influenza Other Respir Viruses. 2020. PMID: 32064773 Free PMC article.
-
Respiratory syncytial virus prophylaxis in infants with congenital airway anomalies compared to standard indications and complex medical disorders.Eur J Pediatr. 2019 Mar;178(3):377-385. doi: 10.1007/s00431-018-03308-1. Epub 2019 Jan 4. Eur J Pediatr. 2019. PMID: 30610419
-
Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005-2016).Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1345-1352. doi: 10.1007/s10096-018-3256-0. Epub 2018 May 4. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29728782
-
Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1113-1118. doi: 10.1007/s10096-018-3225-7. Epub 2018 Mar 19. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29557081
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous